BMO Capital analyst Andrew Strelzik lowered the firm’s price target on Ingredion (INGR) to $120 from $123 and keeps a Market Perform rating on the shares. The firm’s Q4 results missed consensus estimates, reflecting weaker profits in Texture & Healthful Solutions segment, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INGR: